![\"\"](\"https:\/\/www.artefact.com\/\/wp-content\/uploads\/2025\/11\/Mockup-ebook-The-Agentic-AI-Advantage-Healthcare-1.png\")
<\/p>\n<\/p>\n
Artefact<\/a>\u2019s new ebook, The Agentic AI Advantage in Healthcare: Accelerating Pharma\u2019s HCP-Centric Marketing from Insight to Outcome<\/strong><\/em>, demonstrates that agentic AI represents a major step forward in solving these challenges. While traditional generative AI focuses on creating content, agentic AI can take action. It receives goals and constraints, reasons strategically, and executes tasks autonomously within the guardrails of compliance and approved data sources. Agentic AI elevates AI from a productivity tool to a business performance engine.<\/strong><\/p>\n It is clear that agentic AI is poised to redefine marketing, medical engagement, compliance, and the sales model<\/strong>. It is not a futuristic concept. It is already driving measurable return on investment in global organizations. The companies that adopt early will gain a long-term advantage in how they activate data for growth.<\/p>\n \u201cOrganizations that embrace agentic AI will dramatically shorten drug-to-market timelines and gain a critical advantage in speed and efficiency. Those that delay risk falling behind in a future defined by autonomous, personalized, and compliant commercial operations.\u201d<\/em> – Thomas Filaire<\/a>, Global Head of AI Solutions, Artefact<\/strong><\/p>\n Generative AI brought immediate productivity wins: faster content creation, smoother translation workflows, enriched analytics dashboards. But healthcare executives are now facing diminishing returns unless they evolve to models where AI drives execution.<\/p>\n Three market forces make this shift urgent:<\/p>\n Agentic AI addresses these constraints by allowing companies to work at the speed of the market rather than the speed of the approval cycle.<\/p>\n Agentic AI systems go beyond traditional generative models. They don\u2019t just produce outputs, they pursue goals. Their strength lies in combining autonomous behavior with the technological architecture that makes it possible.<\/p>\n Agentic AI systems don\u2019t replace humans, they automate the \u201clast mile\u201d: connecting data insights to action while humans define strategy and oversight. Agents execute rapidly and continuously optimize. For leaders accustomed to cautious innovation cycles, this marks a major mindset shift. Only C-suite guidance can orchestrate this level of change across commercial, medical, IT, and compliance teams.<\/p>\n \u201cAI in the commercial space can be just as impactful – if not even more – than in R&D when it comes to driving benefit, revenue and efficiency.\u201d<\/em> – Florent Hassen<\/a>, Global Commercial Data Science & Artificial Intelligence Lead, Roche<\/strong><\/p>\n Agentic AI is proving its impact in four core areas of healthcare operations. Each one has a practical focus use case that is already delivering measurable ROI for early adopters.<\/p>\n 1) Market research: From static reports to real-time intelligence<\/strong><\/p>\n Focus use case: Rapid campaign testing and optimization<\/em><\/p>\n Commercial teams gain a new operating rhythm. Instead of planning cycles defined by quarterly approvals and manual setup, agents continuously run controlled experiments, optimize based on real-time data, and activate content only when it proves effective. This reduces spend and reveals growth opportunities that would otherwise be missed.<\/p>\n \u201cToday, with this kind of AI tool, we can test campaigns in 12 to 24 hours for around $7,000. When you compare that to the old method – 8 to 10 weeks for $100,000 or $150,000 – it\u2019s difficult to go back.\u201d<\/em> Jeremy Peaudecerf<\/a>, Europe Marketing Director, Moderna<\/strong><\/p>\n 2) Content development and validation<\/strong><\/p>\n Focus use case: Automated pre-checking and accelerated medical reviews<\/em><\/p>\n MLR teams remain gatekeepers of scientific credibility, but agents eliminate repetitive formatting and validation tasks. Automated prechecks flag risks early, while traceable reasoning accelerates approval without compromising compliance.<\/p>\n \u201cWhile still in pilot phase, early results on the MLR review project are promising: 100% of users report satisfaction, time savings, and fewer MLR iterations.\u201d<\/em> – Marie Morice-Morand<\/a>, Associate Director Innovation, Omnichannel and Training, Amgen<\/strong><\/p>\n 3) Campaign execution and omnichannel engagement<\/strong><\/p>\n Focus use case: \u201cTuring\u201d, Sanofi\u2019s Next Best Action companion for HCPs<\/em><\/p>\n Agentic AI unifies behavioral insights, channel preferences, and treatment data to personalize engagement for every HCP. Instead of generic campaigns, each physician receives the right scientific content based on real-time market dynamics and therapeutic relevance.<\/p>\n \u201cTuring acts as a true companion for our reps. By embedding AI suggestions directly into their CRM, we\u2019ve empowered them to deliver the right message to the right HCP at the right time, driving a 10:1 return on our investment.\u201d<\/em> – Marion Dumas<\/a>, Global Head of Omnichannel, Sanofi<\/strong><\/p>\n Individually, each use case moves a specific team faster. Together, they create an enterprise engine where strategy and execution operate in real time, improving ROI, compliance, and customer experience simultaneously.<\/p>\n 4) Sales enablement and field support<\/strong><\/p>\n Focus use case: Rep coaching, preparation, and CRM automation<\/em><\/p>\n Access to HCPs is scarce and every minute matters. Agents prepare reps with tailored engagement plans based on each HCP\u2019s scientific interests, previous interactions, and patient profiles. They also automate visit reporting and suggest next actions.<\/p>\nWhy healthcare must move beyond traditional AI.<\/h2>\n
\n
Five capabilities that make agentic AI different.<\/h2>\n
\n
Where agentic AI delivers enterprise-level value.<\/h2>\n
\n
\n
\n